Cargando…

Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid

BACKGROUND: Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Somenzi, Giulia, Sala, Giusy, Rossetti, Stefano, Ren, MingQiang, Ghidoni, Riccardo, Sacchi, Nicoletta
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959242/
https://www.ncbi.nlm.nih.gov/pubmed/17786207
http://dx.doi.org/10.1371/journal.pone.0000836
_version_ 1782134627172876288
author Somenzi, Giulia
Sala, Giusy
Rossetti, Stefano
Ren, MingQiang
Ghidoni, Riccardo
Sacchi, Nicoletta
author_facet Somenzi, Giulia
Sala, Giusy
Rossetti, Stefano
Ren, MingQiang
Ghidoni, Riccardo
Sacchi, Nicoletta
author_sort Somenzi, Giulia
collection PubMed
description BACKGROUND: Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the “rheostat” comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingolipid with prosurvival activity. METHODOLOGY/PRINCIPAL FINDINGS: We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. CONCLUSIONS/SIGNIFICANCE: In the presence of functional RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA–in a non-RAR-mediated fashion–promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA.
format Text
id pubmed-1959242
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-19592422007-09-05 Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid Somenzi, Giulia Sala, Giusy Rossetti, Stefano Ren, MingQiang Ghidoni, Riccardo Sacchi, Nicoletta PLoS One Research Article BACKGROUND: Retinoic acid (RA), the bioactive derivative of Vitamin A, by epigenetically controlling transcription through the RA-receptors (RARs), exerts a potent antiproliferative effect on human cells. However, a number of studies show that RA can also promote cell survival and growth. In the course of one of our studies we observed that disruption of RA-receptor alpha, RARα, abrogates the RA-mediated growth-inhibitory effects and unmasks the growth-promoting face of RA (Ren et al., Mol. Cell. Biol., 2005, 25:10591). The objective of this study was to investigate whether RA can differentially govern cell growth, in the presence and absence of RARα, through differential regulation of the “rheostat” comprising ceramide (CER), the sphingolipid with growth-inhibitory activity, and sphingosine-1-phosphate (S1P), the sphingolipid with prosurvival activity. METHODOLOGY/PRINCIPAL FINDINGS: We found that functional inhibition of endogenous RARα in breast cancer cells by using either RARα specific antagonists or a dominant negative RARα mutant hampers on one hand the RA-induced upregulation of neutral sphingomyelinase (nSMase)-mediated CER synthesis, and on the other hand the RA-induced downregulation of sphingosine kinase 1, SK1, pivotal for S1P synthesis. In association with RA inability to regulate the sphingolipid rheostat, cells not only survive, but also grow more in response to RA both in vitro and in vivo. By combining genetic, pharmacological and biochemical approaches, we mechanistically demonstrated that RA-induced growth is, at least in part, due to non-RAR-mediated activation of the SK1-S1P signaling. CONCLUSIONS/SIGNIFICANCE: In the presence of functional RARα, RA inhibits cell growth by concertedly, and inversely, modulating the CER and S1P synthetic pathways. In the absence of a functional RARα, RA–in a non-RAR-mediated fashion–promotes cell growth by activating the prosurvival S1P signaling. These two distinct, yet integrated processes apparently concur to the growth-promoter effects of RA. Public Library of Science 2007-09-05 /pmc/articles/PMC1959242/ /pubmed/17786207 http://dx.doi.org/10.1371/journal.pone.0000836 Text en Somenzi et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Somenzi, Giulia
Sala, Giusy
Rossetti, Stefano
Ren, MingQiang
Ghidoni, Riccardo
Sacchi, Nicoletta
Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title_full Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title_fullStr Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title_full_unstemmed Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title_short Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
title_sort disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1959242/
https://www.ncbi.nlm.nih.gov/pubmed/17786207
http://dx.doi.org/10.1371/journal.pone.0000836
work_keys_str_mv AT somenzigiulia disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid
AT salagiusy disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid
AT rossettistefano disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid
AT renmingqiang disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid
AT ghidoniriccardo disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid
AT sacchinicoletta disruptionofretinoicacidreceptoralpharevealsthegrowthpromoterfaceofretinoicacid